Carregant...
Market access pathways for cell therapies in France
INTRODUCTION AND OBJECTIVE: Cell therapies can be classified into three main categories of products: advanced therapy medicinal products (ATMPs), ATMPs prepared on a non-routine basis (hospital exemptions), and minimally manipulated cells. Despite the benefits that cell therapies can bring to patien...
Guardat en:
| Publicat a: | J Mark Access Health Policy |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Co-Action Publishing
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4802688/ https://ncbi.nlm.nih.gov/pubmed/27123176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3402/jmahp.v3.29094 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|